Category

Countries

Wood Plans Expansion of Key Biopharmaceutical Manufacturing Facility in South Korea
Wood Plans Expansion of Key Biopharmaceutical Manufacturing Facility in South Korea

Wood Plans Expansion of Key Biopharmaceutical Manufacturing Facility in South Korea

  • 08-Apr-2024 6:09 PM
  • Journalist: Kim Chul Son

Wood Plc, a renowned leader in consulting and engineering services, has been entrusted by Celltrion, a prominent biopharmaceutical company, to spearhead the expansion of its Songdo biopharma manufacturing hub in Incheon, South Korea. This partnership entails Wood providing comprehensive engineering design services for a new facility poised to significantly augment the manufacturing capacity of biological medicines by an impressive eight million liquid vials per annum. This strategic endeavor aims to address the surging global demand for biopharmaceutical drug products.

By leveraging Wood's unparalleled process engineering design capabilities, Celltrion seeks to fortify its product pipeline and secure enhanced manufacturing capacity. Wood's expertise is anticipated to play a pivotal role in optimizing production efficiency for Celltrion, consequently minimizing downtime associated with transitioning equipment between different product lines. The ultimate objective is to achieve operational cost savings while bolstering manufacturing capabilities.

Jim Goff, Senior Vice President of Life Sciences at Wood, expressed immense pride in being chosen as Celltrion's engineering partner for this monumental endeavor. He underscored the critical importance of Celltrion's new facility in ensuring a secure and stable supply of life-saving medications for treating various ailments, including cancer, autoimmune diseases, and neurological disorders.

Goff emphasized Wood's unwavering commitment to delivering projects with utmost precision, adhering to the highest safety and quality standards. He highlighted the company's distinctive process design expertise, which is poised to imbue Celltrion's operations with agility, thereby driving efficiencies in production, time, and costs. By aligning with Celltrion's mission to expand global access to innovative biologics, Wood aims to contribute to creating a healthier world.

The project will be executed by Wood's team of seasoned Life Sciences experts, drawing upon their wealth of experience and knowledge from Europe and India. The anticipated timeline for project completion is set for the third quarter of 2024, with commercial operations slated to commence in 2027.

Wood Group plc, often referred to as Wood, is a multinational engineering and consulting corporation headquartered in Aberdeen, Scotland. It is publicly traded on the London Stock Exchange and is included in the FTSE 250 Index. Ian Wood founded the company in 1982 after it broke away from JW Holdings, Scotland's largest fishing company. JW Holdings had expanded into the energy services sector during the emergence of the North Sea oil industry in the early 1970s. In September 2000, Wood Group plc acquired Mustang Engineering Inc, an engineering firm located in Houston, Texas.

Related News

Pharmaceutical Market in Flux: Paracetamol API Prices Plummet Amidst Global Supply Chain Dynamics
  • 03-May-2024 4:36 PM
  • Journalist: Francis Stokes
Global Paracetamol Prices Experience Volatility Amid Geopolitical Tensions and Supply Chain Disruptions
  • 03-Jan-2024 3:05 PM
  • Journalist: Nina Jiang
Stable Decrease in Paracetamol Prices Marks December Pharmaceutical Landscape
  • 20-Dec-2023 3:35 PM
  • Journalist: Emilia Jackson
Government Sounds Alarm on Adverse Effects of Popular Painkiller Meftal
  • 15-Dec-2023 2:04 PM
  • Journalist: Kim Chul Son